HBAN(HBAN)
HBAN
Q4 2026 EPS Estimate
$0.40
Oct 22, 2026 · Reports before open
Revenue Estimate
$2.88B
FY2026E EPS$1.40
FY2027E EPS$1.89
Analyst Sentiment
Wall St. Consensus
Buy25 analysts·High coverage
63
Score
13 Buy (52%)11 Hold (44%)1 Sell (4%)
Rating Breakdown
Strong Buy
14%
Buy
1248%
Hold
1144%
Sell
14%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$18.00
+0.1%
Consensus
$20.50
+14.0%
Bull
$22.00
+22.3%
12-Month Target Range25 analysts
$18.00$20.50$22.00
Current $17.98Consensus
Current Price
$17.98
Upside to Consensus
$2.52
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+9.10%
EPS+34.24%
FY2028
Rev+6.51%
EPS+11.84%
FY2029
Rev-37.27%
EPS-17.97%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $11.26B | $12.29B | $13.09B | $8.21B |
| Low | $11.18B | $12.13B | $12.91B | $8.11B |
| High | $11.31B | $12.52B | $13.36B | $8.32B |
| EBITDA Avg | $3.51B | $3.83B | $4.08B | $2.56B |
| Low | $3.49B | $3.78B | $4.02B | $2.53B |
| High | $3.53B | $3.90B | $4.16B | $2.59B |
| EBIT Avg | $2.81B | $3.06B | $3.26B | $2.05B |
| Low | $2.79B | $3.02B | $3.22B | $2.02B |
| High | $2.82B | $3.12B | $3.33B | $2.07B |
| Net Income Avg | $2.10B | $2.82B | $3.01B | $2.60B |
| Low | $2.05B | $2.72B | $2.60B | $2.56B |
| High | $2.15B | $2.91B | $3.43B | $2.65B |
| EPS Avg | $1.40 | $1.89 | $2.11 | $1.73 |
| Low | $1.36 | $1.81 | $1.73 | $1.70 |
| High | $1.43 | $1.94 | $2.28 | $1.76 |
| Analysts (Rev / EPS) | 5 / 12 | 5 / 12 | 3 / 5 | 1 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $2.88B | $2.96B | $2.94B | $3.05B | $3.13B | $3.19B | $3.23B | $3.30B |
| Low | $2.85B | $2.92B | $2.91B | $3.01B | $3.10B | $3.16B | $3.20B | $3.26B |
| High | $2.90B | $3.00B | $2.98B | $3.08B | $3.16B | $3.22B | $3.27B | $3.33B |
| EBITDA Avg | $898M | $922M | $918M | $950M | $975M | $994M | $1.01B | $1.03B |
| Low | $889M | $910M | $908M | $940M | $965M | $984M | $997M | $1.02B |
| High | $905M | $935M | $928M | $960M | $986M | $1.01B | $1.02B | $1.04B |
| EBIT Avg | $718M | $737M | $734M | $760M | $780M | $795M | $806M | $822M |
| Low | $711M | $728M | $726M | $752M | $772M | $787M | $797M | $813M |
| High | $724M | $747M | $742M | $768M | $788M | $804M | $814M | $830M |
| Net Income Avg | $735M | $849M | $862M | $913M | $970M | $1.01B | $974M | $1.02B |
| Low | $698M | $792M | $850M | $901M | $957M | $992M | $960M | $1.01B |
| High | $772M | $888M | $874M | $926M | $983M | $1.02B | $987M | $1.03B |
| EPS Avg | $0.37 | $0.43 | $0.44 | $0.46 | $0.49 | $0.51 | $0.49 | $0.52 |
| Low | $0.35 | $0.40 | $0.43 | $0.46 | $0.48 | $0.50 | $0.49 | $0.51 |
| High | $0.39 | $0.45 | $0.44 | $0.47 | $0.50 | $0.52 | $0.50 | $0.52 |
| Analysts (Rev / EPS) | 4 / 9 | 4 / 8 | 2 / 3 | 2 / 4 | 2 / 3 | 2 / 4 | 1 / 4 | 1 / 5 |